Lidocaine Hydrochloride Jelly
Product Images NDC 51662-1552

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 51662-1552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1552 2 Pouch Labeling)

Pouch Labeling (51662 1552 2 Pouch Labeling)
Label for Lidocaine Hydrochloride Jelly USP 2%, 20 mg/mL, in a 10 mL Uro-Jet syringe. The label includes NDC 51662-1552-2, lot number 12345, and expiration date 2025-01-01. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. Contains dosage and storage instructions for this topical local anesthetic.*
FDA Label Image

Case Labeling (51662 1552 3 Case Labeling)

Case Labeling (51662 1552 3 Case Labeling)
Lidocaine Hydrochloride Jelly USP 2%, 20 mg/mL, 10 mL URO-JET package label. Displayed are details including NDC 51662-1552-3, lot number 12345, and expiration date 2025-01-01. The label states the product is for topical use as a local anesthetic, with storage instructions at controlled room temperature. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Serialized Label (51662 1552 3 Serialized Labeling)

Serialized Label (51662 1552 3 Serialized Labeling)
A product label for Lidocaine Hydrochloride topical jelly distributed by HF Acquisition Co., LLC in Mukilteo, WA. The label includes a barcode and text noting 'See manufacturer's package insert' and 'RX ONLY', along with a series of numeric codes and a date.*
FDA Label Image

Description (Description)

Description (Description)
Chemical structure of Lidocaine Hydrochloride showing its molecular formula with aromatic ring, amide linkage, and hydrochloride salt.*
FDA Label Image

Hs1 (How Supplied 1)

Hs1 (How Supplied 1)
A data table listing Stock Numbers, NDC codes, and Stock No. identifiers for LIDOCAINE HYDROCHLORIDE jelly in three sizes: 5 mL, 10 mL, and 20 mL. Each size has a corresponding NDC code and Stock No.*
FDA Label Image

Hs2 (How Supplied 2)

Hs2 (How Supplied 2)
A data table showing size and stock number details for a product. It lists a 5 mL size, with corresponding NDC 76329-3011-5, and stock number 3011-SP.*
FDA Label Image

Hs3 (How Supplied 3)

Hs3 (How Supplied 3)
Instructional illustrations showing three steps for preparing an injection: opening a sterile pouch and dropping contents onto a sterile field, threading a vial into an injector with caution not to push it fully to avoid misalignment, and removing the cap to expel air. Each step is depicted with hand drawings and corresponding text instructions.*
FDA Label Image

Urojet (Urojet Labeling)

Urojet (Urojet Labeling)
Label for Lidocaine Hydrochloride Jelly USP, 2%, 200 mg (20 mg/mL) in a 10 mL Sterile Pak URO-JET. The product is for topical use only as a local anesthetic and is single-use with no preservative added. It is manufactured by International Medication Systems, Limited, El Monte, CA, and includes instructions for sterile use and syringe assembly.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.